Description
Nivolumab prolongs the survival of patients with advanced renal cell cancer
Article: Nivolumab prolongs the survival of patients with advanced renal cell cancer
€3.03
Related products
-
Article: Highlights in respiratory oncology
€3.03 Add to cart -
Article: Highlights in breast cancer
€3.03 Add to cart -
Article: Highlights in melanoma
€3.03 Add to cart -
Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer
€3.03 Add to cart
